Erratum to: Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis

Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-010-1096-4

The authors regret to report typographical errors in the original publication and would like to make the following corrections.

Line 17 of the Abstract should read: Hot flashes were more prevalent…

Line 12 of the Methods section should read: …341 (5.4%) could not be contacted…

The fifth sentence of the “Statistical analysis” section should read: Distributions of sociodemographic, lifestyle, and clinical factors were estimated among breast cancer patients at 6 and 36 months postdiagnosis.

Line 15 of the Results section should read: …vs. 55.6 years…

For the results presented in the paper, please refer to the new tables below for corrected numbers.

Table 1 Distribution of demographic, lifestyle and clinical characteristics for breast cancer patients at 6 and 36 months postdiagnosis, the Shanghai Breast Cancer Survival Study (SBCSS)

Table 2 Age-adjusted distributions for demographic, lifestyle and clinical characteristics of breast cancer patients by presence of any menopausal symptom (MPS^a) at 6 and 36 months postdiagnosis, the SBCSS

Table 3 Association of soy isoflavone intake and MPS among breast cancer patients at 6 and 36 months postdiagnosis stratified by menopausal status, the SBCSS

Table 4 Association between isoflavone intake and MPS among breast cancer patients at 6 and 36 months postdiagnosis stratified by current tamoxifen use, the SBCSS

Table 5 Association between isoflavone intake and MPS among breast cancer patients at 6 and 36 months postdiagnosis stratified by BMI, the SBCSS